BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu B, Hu X, Jiang Z, Li H, Chen J, Cui S, Li Q, Liao N, Liu D, Liu J, Lu J, Shen K, Sun T, Teng Y, Tong Z, Wang S, Wang X, Wang X, Wang Y, Wu J, Yuan P, Zhang P, Zhang Q, Zheng H, Pang D, Ren G, Shao Z, Shen Z, Song E, Song S. National consensus in China on diagnosis and treatment of patients with advanced breast cancer. Ann Transl Med 2015;3:242. [PMID: 26605288 DOI: 10.3978/j.issn.2305-5839.2015.09.47] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Ren C, Wen L, Chen X, Chen B, Zhang G, Wang Y, Li K, Cao L, Jia M, Mok H, Lai J, Xiao W, Li X, Liao N. Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature. Clin Med Insights Oncol 2022;16:11795549211072880. [PMID: 35237089 DOI: 10.1177/11795549211072880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tu He Ta Mi Shi ME, Wang N, Yao Q, Dong SS, Feng X, Zhao J, Zou H, Pang LJ, Qi Y. A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review. Onco Targets Ther 2021;14:3003-11. [PMID: 33986601 DOI: 10.2147/OTT.S298379] [Reference Citation Analysis]
3 Xu F, Zheng Q, Xia W, Ouyang Q, Pang D, Yuan Z, Shi Y, Peng R, Lu Q, Wang S. A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line Chemotherapy. Oncologist 2021;26:e742-8. [PMID: 33245164 DOI: 10.1002/onco.13614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Maes-Carballo M, Muñoz-Núñez I, Martín-Díaz M, Mignini L, Bueno-Cavanillas A, Khan KS. Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review. Health Expect 2020;23:1045-64. [PMID: 32748514 DOI: 10.1111/hex.13112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhao W, Tian Q, Zhao A, Wang B, Yang J, Wang L, Zhang L, Dong D, Chen L, Yang J. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis. Breast Cancer 2021;28:110-8. [PMID: 32748225 DOI: 10.1007/s12282-020-01135-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu XF, Li JW, Chen HZ, Sun ZY, Shi GX, Zhu JM, Song AL, Wang Y, Li XQ. Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling. Biosci Rep 2019;39:BSR20181260. [PMID: 30429238 DOI: 10.1042/BSR20181260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Zhou ZR, Han Q, Liang SX, He XD, Cao NY, Zi YJ. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study. Oncotarget 2017;8:33855-63. [PMID: 27806340 DOI: 10.18632/oncotarget.12979] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Liu X, Yu H, Qiao Y, Yang J, Shu J, Zhang J, Zhang Z, He J, Li Z. Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer. EBioMedicine 2018;28:70-9. [PMID: 29402727 DOI: 10.1016/j.ebiom.2018.01.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
9 Zhao X, Zhao J, Hu R, Yao Q, Zhang G, Shen H, Yagüe E, Hu Y. Ruanjian Sanjie decoction exhibits antitumor activity by inducing cell apoptosis in breast cancer. Oncol Lett 2017;13:3071-9. [PMID: 28529560 DOI: 10.3892/ol.2017.5832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
10 Zhou ZR, Wang CC, Yang ZZ, Yu XL, Guo XM. Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis 2016;8:3361-8. [PMID: 28066617 DOI: 10.21037/jtd.2016.11.03] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
11 Zhou ZR, Yang ZZ, Yu XL, Guo XM. Is internal mammary nodes irradiation as a part of breast cancer postoperative radiotherapy necessary? J Thorac Dis 2016;8:3427-30. [PMID: 28066623 DOI: 10.21037/jtd.2016.11.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]